alexa Insulin-like Growth Factor II Reverses Memory And Synaptic Impairments In APP Transgenic Mice | 21943
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Alzheimers Disease and Dementia

Ana Gracia Osta, Garcia-Barroso C, Ugarte A, Oyarazabal J and Mar Cuadrado-Tejedor
ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism
DOI: 10.4172/2161-0460.S1.006
Abstract
Insulin-like growth factor II (IGF2) is a circulating hormone, which together with insulin and insulin-like growth factor I (IGF1), belongs to the IGF/IGFBP (IGF/IGF binding protein) system. Insulin and IGF1, more than IGF2, have been related to the pathogeneis of Alzheimer?s disease (AD). Nevertheless, a recent study showed that administering IGF2 in the hippocampus of rats significantly enhances memory retention and prevents forgetting, suggesting that IGF2 is critically involved in memory consolidation. Other studies showed that systemic administration of IGF1 reduced amyloid load without affecting memory function. Altogether, these findings point out that administering IGF2 in the hippocampus could be a promising alternative to the treatment of Alzheimer?s disease (AD). In this study we used recombinant adeno-associated viral (rAAV) vectors to provide IGF2 and IGF1 specifically into the hippocampus of an APP mouse model. We found that IGF2 expression decreases in the hippocampus of AD patients, leading us to hypothesize that the administration of IGF2 could ameliorate AD symptoms. We report that increasing hippocampal levels of IGF2 and IGF1 via AAV-mediated expression rescue behavioural deficits, promote dendritic spine formation and restores normal hippocampal excitatory synaptic transmission in Tg2576 mice. Finally, AAV-IGF2-expressing mice have significantly less amyloid levels than AAV-IGF1-expressing or sham Tg2576 mice. Notably, the regulation of amyloid levels in neuronal population may occurs through an interaction with the IGF2R. Hence, IGF2 may represent novel therapeutic targets for the treatment of AD.
Biography
Ana Gracia Osta received her Bachelor Degree and her PhD in Pharmacy from the University of Navarra, Spain. Her postdoctoral training was obtained in the Alberini?s laboratory, in the Neuroscience Department at the Mount Sinai School of Medicine in New York. She joined the Neuroscience Department of CIMA in 2007. She is a Investigator in the laboratory of Neurobiology of Alzheimer?s disease and she interested in the investigation of molecular basis of dementia in Alzheimer Disease. As an independent group, she leads several projects related to the search for new therapeutic targets to reverse the dementia associated with the pathology of Alzheimer?s disease.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7